{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:12:13Z","timestamp":1790017933064,"version":"4.0.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T00:00:00Z","timestamp":1446163200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004212","name":"P\u00e4ivikki ja Sakari Sohlbergin S\u00e4\u00e4ti\u00f6 (FI)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004212","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s40266-015-0321-6","type":"journal-article","created":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T09:36:12Z","timestamp":1446197772000},"page":"963-974","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Central Anticholinergic Adverse Effects and Their Measurement"],"prefix":"10.1007","volume":"32","author":[{"given":"Pasi","family":"Lampela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teemu","family":"Paajanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirpa","family":"Hartikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risto","family":"Huupponen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,30]]},"reference":[{"key":"321_CR1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.arr.2010.04.005","volume":"9","author":"S Stegemann","year":"2010","unstructured":"Stegemann S, Ecker F, Maio M, et al. Geriatric drug therapy: neglecting the inevitable majority. Ageing Res Rev. 2010;9:384\u201398.","journal-title":"Ageing Res Rev."},{"key":"321_CR2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2125.2004.02232.x","volume":"59","author":"N Lechevallier-Michel","year":"2005","unstructured":"Lechevallier-Michel N, Molimard M, Dartigues JF, et al. Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study. Br J Clin Pharmacol. 2005;59:143\u201351.","journal-title":"Br J Clin Pharmacol."},{"key":"321_CR3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/bmj.38740.439664.DE","volume":"332","author":"ML Ancelin","year":"2006","unstructured":"Ancelin ML, Artero S, Portet F, et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ. 2006;332:455\u20139.","journal-title":"BMJ."},{"key":"321_CR4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.amjopharm.2006.03.008","volume":"4","author":"J Ness","year":"2006","unstructured":"Ness J, Hoth A, Barnett MJ, et al. Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events. Am J Geriatr Pharmacother. 2006;4:42\u201351.","journal-title":"Am J Geriatr Pharmacother."},{"key":"321_CR5","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archinte.167.8.781","volume":"167","author":"SN Hilmer","year":"2007","unstructured":"Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167:781\u20137.","journal-title":"Arch Intern Med."},{"key":"321_CR6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000325171","volume":"31","author":"G Sittironnarit","year":"2011","unstructured":"Sittironnarit G, Ames D, Bush AI, et al. Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study. Dement Geriatr Cogn Disord. 2011;31:173\u20138.","journal-title":"Dement Geriatr Cogn Disord."},{"key":"321_CR7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/106002808301700618","volume":"17","author":"R Seifert","year":"1983","unstructured":"Seifert R, Jamieson J, Gardner R Jr. Use of anticholinergics in the nursing home: an empirical study and review. Drug Intell Clin Pharm. 1983;17:470\u20133.","journal-title":"Drug Intell Clin Pharm."},{"key":"321_CR8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jamda.2008.11.005","volume":"10","author":"A Kolanowski","year":"2009","unstructured":"Kolanowski A, Fick DM, Campbell J, et al. A preliminary study of anticholinergic burden and relationship to a quality of life indicator, engagement in activities, in nursing home residents with dementia. J Am Med Dir Assoc. 2009;10:252\u20137.","journal-title":"J Am Med Dir Assoc."},{"key":"321_CR9","doi-asserted-by":"crossref","first-page":"869","DOI":"10.4088\/JCP.11ac07093","volume":"72","author":"P Gerretsen","year":"2011","unstructured":"Gerretsen P, Pollock BG. Rediscovering adverse anticholinergic effects. J Clin Psychiatry. 2011;72:869\u201370.","journal-title":"J Clin Psychiatry."},{"key":"321_CR10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.bjp.0706780","volume":"148","author":"P Abrams","year":"2006","unstructured":"Abrams P, Andersson KE, Buccafusco JJ, et al. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol. 2006;148:565\u201378.","journal-title":"Br J Pharmacol."},{"issue":"Suppl 3","key":"321_CR11","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.33549\/physiolres.931449","volume":"57","author":"J Jakubik","year":"2008","unstructured":"Jakubik J, Michal P, Machova E, et al. Importance and prospects for design of selective muscarinic agonists. Physiol Res. 2008;57(Suppl 3):S39\u201347.","journal-title":"Physiol Res."},{"key":"321_CR12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrd4295","volume":"13","author":"AC Kruse","year":"2014","unstructured":"Kruse AC, Kobilka BK, Gautam D, et al. Muscarinic acetylcholine receptors: novel opportunities for drug development. Nat Rev Drug Discov. 2014;13:549\u201360.","journal-title":"Nat Rev Drug Discov."},{"key":"321_CR13","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/j.1742-1241.2008.01849.x","volume":"62","author":"GG Kay","year":"2008","unstructured":"Kay GG, Ebinger U. Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin. Int J Clin Pract. 2008;62:1792\u2013800.","journal-title":"Int J Clin Pract."},{"key":"321_CR14","first-page":"184","volume-title":"Goodman and Gilmans\u2019s, the pharmacological basis of therapeutics","author":"JH Brown","year":"2005","unstructured":"Brown JH, Taylor P. Muscarinic receptor agonists and antagonists. In: Brunton L, Lazo J, Parker K, editors. Goodman and Gilmans\u2019s, the pharmacological basis of therapeutics. USA: The McGraw-Hill Companies; 2005. p. 184\u20136."},{"key":"321_CR15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/pds.2169","volume":"21","author":"M Wawruch","year":"2012","unstructured":"Wawruch M, Macugova A, Kostkova L, et al. The use of medications with anticholinergic properties and risk factors for their use in hospitalised elderly patients. Pharmacoepidemiol Drug Saf. 2012;21:170\u20136.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"321_CR16","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s12325-009-0074-x","volume":"26","author":"RA Flynn","year":"2009","unstructured":"Flynn RA, Glynn DA, Kennedy MP. Anticholinergic treatment in airways diseases. Adv Ther. 2009;26:908\u201319.","journal-title":"Adv Ther."},{"key":"321_CR17","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jagp.2013.01.012","volume":"21","author":"AA Mangoni","year":"2013","unstructured":"Mangoni AA, van Munster BC, Woodman RJ, et al. Measures of anticholinergic drug exposure, serum anticholinergic activity, and all-cause postdischarge mortality in older hospitalized patients with hip fractures. Am J Geriatr Psychiatry. 2013;21:785\u201393.","journal-title":"Am J Geriatr Psychiatry."},{"key":"321_CR18","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/0091270006292126","volume":"46","author":"RM Carnahan","year":"2006","unstructured":"Carnahan RM, Lund BC, Perry PJ, et al. The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol. 2006;46:1481\u20136.","journal-title":"J Clin Pharmacol."},{"key":"321_CR19","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1532-5415.2008.01737.x","volume":"56","author":"ML Chew","year":"2008","unstructured":"Chew ML, Mulsant BH, Pollock BG, et al. Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc. 2008;56:1333\u201341.","journal-title":"J Am Geriatr Soc."},{"key":"321_CR20","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","volume":"168","author":"JL Rudolph","year":"2008","unstructured":"Rudolph JL, Salow MJ, Angelini MC, et al. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008;168:508\u201313.","journal-title":"Arch Intern Med."},{"key":"321_CR21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00228-005-0953-2","volume":"61","author":"J Penttil\u00e4","year":"2005","unstructured":"Penttil\u00e4 J, Kuusela T, Scheinin H. Analysis of rapid heart rate variability in the assessment of anticholinergic drug effects in humans. Eur J Clin Pharmacol. 2005;61:559\u201365.","journal-title":"Eur J Clin Pharmacol."},{"key":"321_CR22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1055\/s-2005-873152","volume":"38","author":"J Penttil\u00e4","year":"2005","unstructured":"Penttil\u00e4 J, Scheinin H, Syv\u00e4lahti E. Measurement of anticholinergic effects of psychotropic drugs in humans. Pharmacopsychiatry. 2005;38:187\u201393.","journal-title":"Pharmacopsychiatry."},{"key":"321_CR23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/jnr.490270418","volume":"27","author":"SL Dewey","year":"1990","unstructured":"Dewey SL, Volkow ND, Logan J, et al. Age-related decreases in muscarinic cholinergic receptor binding in the human brain measured with positron emission tomography (PET). J Neurosci Res. 1990;27:569\u201375.","journal-title":"J Neurosci Res."},{"key":"321_CR24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neurobiolaging.2007.07.015","volume":"30","author":"AJ Farrall","year":"2009","unstructured":"Farrall AJ, Wardlaw JM. Blood-brain barrier: ageing and microvascular disease: systematic review and meta-analysis. Neurobiol Aging. 2009;30:337\u201352.","journal-title":"Neurobiol Aging."},{"key":"321_CR25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2990.2008.01005.x","volume":"35","author":"HB Stolp","year":"2009","unstructured":"Stolp HB, Dziegielewska KM. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases. Neuropathol Appl Neurobiol. 2009;35:132\u201346.","journal-title":"Neuropathol Appl Neurobiol."},{"key":"321_CR26","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.bbamem.2008.10.022","volume":"1788","author":"N Weiss","year":"2009","unstructured":"Weiss N, Miller F, Cazaubon S, et al. The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta. 2009;1788:842\u201357.","journal-title":"Biochim Biophys Acta."},{"key":"321_CR27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1532-5415.2008.02129.x","volume":"57","author":"J Uusvaara","year":"2009","unstructured":"Uusvaara J, Pitk\u00e4l\u00e4 KH, Tienari PJ, et al. Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study. J Am Geriatr Soc. 2009;57:427\u201331.","journal-title":"J Am Geriatr Soc."},{"key":"321_CR28","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archpsyc.60.2.198","volume":"60","author":"BH Mulsant","year":"2003","unstructured":"Mulsant BH, Pollock BG, Kirshner M, et al. Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry. 2003;60:198\u2013203.","journal-title":"Arch Gen Psychiatry."},{"key":"321_CR29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s40266-013-0063-2","volume":"30","author":"P Lampela","year":"2013","unstructured":"Lampela P, Lavikainen P, Garcia-Horsman JA, et al. Anticholinergic drug use, serum anticholinergic activity, and adverse drug events among older people: a population-based study. Drugs Aging. 2013;30:321\u201330.","journal-title":"Drugs Aging."},{"key":"321_CR30","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1176\/ajp.140.7.930","volume":"140","author":"FM Mondimore","year":"1983","unstructured":"Mondimore FM, Damlouji N, Folstein MF, et al. Post-ECT confusional states associated with elevated serum anticholinergic levels. Am J Psychiatry. 1983;140:930\u20131.","journal-title":"Am J Psychiatry."},{"key":"321_CR31","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00019442-200307000-00009","volume":"11","author":"CJ Lu","year":"2003","unstructured":"Lu CJ, Tune LE. Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease. Am J Geriatr Psychiatry. 2003;11:458\u201361.","journal-title":"Am J Geriatr Psychiatry."},{"key":"321_CR32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/ajp.145.3.342","volume":"145","author":"PS Miller","year":"1988","unstructured":"Miller PS, Richardson JS, Jyu CA, et al. Association of low serum anticholinergic levels and cognitive impairment in elderly presurgical patients. Am J Psychiatry. 1988;145:342\u20135.","journal-title":"Am J Psychiatry."},{"key":"321_CR33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1176\/appi.ajp.161.1.116","volume":"161","author":"MJ Minzenberg","year":"2004","unstructured":"Minzenberg MJ, Poole JH, Benton C, et al. Association of anticholinergic load with impairment of complex attention and memory in schizophrenia. Am J Psychiatry. 2004;161:116\u201324.","journal-title":"Am J Psychiatry."},{"key":"321_CR34","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.1992.03480060073033","volume":"267","author":"JD Schor","year":"1992","unstructured":"Schor JD, Levkoff SE, Lipsitz LA, et al. Risk factors for delirium in hospitalized elderly. JAMA. 1992;267:827\u201331.","journal-title":"JAMA."},{"key":"321_CR35","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(81)90994-6","volume":"2","author":"LE Tune","year":"1981","unstructured":"Tune LE, Damlouji NF, Holland A, et al. Association of postoperative delirium with raised serum levels of anticholinergic drugs. Lancet. 1981;2:651\u20133.","journal-title":"Lancet."},{"key":"321_CR36","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/archinte.161.8.1099","volume":"161","author":"L Han","year":"2001","unstructured":"Han L, McCusker J, Cole M, et al. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med. 2001;161:1099\u2013105.","journal-title":"Arch Intern Med."},{"key":"321_CR37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000321591","volume":"63","author":"K Hori","year":"2011","unstructured":"Hori K, Konishi K, Watanabe K, et al. Influence of anticholinergic activity in serum on clinical symptoms of Alzheimer\u2019s disease. Neuropsychobiology. 2011;63:147\u201353.","journal-title":"Neuropsychobiology."},{"key":"321_CR38","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1468-1331.2004.00897.x","volume":"11","author":"L Caeiro","year":"2004","unstructured":"Caeiro L, Ferro JM, Claro MI, et al. Delirium in acute stroke: a preliminary study of the role of anticholinergic medications. Eur J Neurol. 2004;11:699\u2013704.","journal-title":"Eur J Neurol."},{"key":"321_CR39","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1345\/aph.1P650","volume":"45","author":"M Teramura-Gr\u00f6nblad","year":"2011","unstructured":"Teramura-Gr\u00f6nblad M, Muurinen S, Soini H, et al. Use of anticholinergic drugs and cholinesterase inhibitors and their association with psychological well-being among frail older adults in residential care facilities. Ann Pharmacother. 2011;45:596\u2013602.","journal-title":"Ann Pharmacother."},{"key":"321_CR40","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jamda.2011.03.006","volume":"12","author":"E Lowry","year":"2011","unstructured":"Lowry E, Woodman RJ, Soiza RL, et al. Associations between the anticholinergic risk scale score and physical function: potential implications for adverse outcomes in older hospitalized patients. J Am Med Dir Assoc. 2011;12:565\u201372.","journal-title":"J Am Med Dir Assoc."},{"key":"321_CR41","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1177\/0091270011421489","volume":"52","author":"E Lowry","year":"2012","unstructured":"Lowry E, Woodman RJ, Soiza RL, et al. Drug burden index, physical function, and adverse outcomes in older hospitalized patients. J Clin Pharmacol. 2012;52:1584\u201391.","journal-title":"J Clin Pharmacol."},{"key":"321_CR42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.amjopharm.2012.06.003","volume":"10","author":"S Koshoedo","year":"2012","unstructured":"Koshoedo S, Soiza RL, Purkayastha R, et al. Anticholinergic drugs and functional outcomes in older patients undergoing orthopaedic rehabilitation. Am J Geriatr Pharmacother. 2012;10:251\u20137.","journal-title":"Am J Geriatr Pharmacother."},{"key":"321_CR43","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1111\/j.1532-5415.2008.02009.x","volume":"56","author":"L Han","year":"2008","unstructured":"Han L, Agostini JV, Allore HG. Cumulative anticholinergic exposure is associated with poor memory and executive function in older men. J Am Geriatr Soc. 2008;56:2203\u201310.","journal-title":"J Am Geriatr Soc."},{"key":"321_CR44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1176\/ajp.145.1.107","volume":"145","author":"BW Rovner","year":"1988","unstructured":"Rovner BW, David A, Lucas-Blaustein MJ, et al. Self-care capacity and anticholinergic drug levels in nursing home patients. Am J Psychiatry. 1988;145:107\u20139.","journal-title":"Am J Psychiatry."},{"key":"321_CR45","first-page":"937","volume":"171","author":"S Cho","year":"2011","unstructured":"Cho S, Lau SW, Tandon V, et al. Geriatric drug evaluation: where are we now and where should we be in the future? Arch Intern Med. 2011;171:937\u201340.","journal-title":"Arch Intern Med."},{"key":"321_CR46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pscychresns.2012.04.014","volume":"204","author":"JA Wojtalik","year":"2012","unstructured":"Wojtalik JA, Eack SM, Pollock BG, et al. Prefrontal gray matter morphology mediates the association between serum anticholinergicity and cognitive functioning in early course schizophrenia. Psychiatry Res. 2012;204:61\u20137.","journal-title":"Psychiatry Res."},{"key":"321_CR47","doi-asserted-by":"crossref","first-page":"459013","DOI":"10.1155\/2014\/459013","volume":"2014","author":"K Hori","year":"2014","unstructured":"Hori K, Konishi K, Tani M, et al. Serum anticholinergic activity: a possible peripheral marker of the anticholinergic burden in the central nervous system in Alzheimer\u2019s disease. Dis Markers. 2014;2014:459013.","journal-title":"Dis Markers."},{"key":"321_CR48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/archpsyc.1980.01780160063007","volume":"37","author":"L Tune","year":"1980","unstructured":"Tune L, Coyle JT. Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects. Arch Gen Psychiatry. 1980;37:293\u20137.","journal-title":"Arch Gen Psychiatry."},{"key":"321_CR49","first-page":"24","volume":"36","author":"RM Carnahan","year":"2002","unstructured":"Carnahan RM, Lund BC, Perry PJ, et al. A critical appraisal of the utility of the serum anticholinergic activity assay in research and clinical practice. Psychopharmacol Bull. 2002;36:24\u201339.","journal-title":"Psychopharmacol Bull."},{"key":"321_CR50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00019442-199802000-00005","volume":"6","author":"JM Flacker","year":"1998","unstructured":"Flacker JM, Cummings V, Mach JR, et al. The association of serum anticholinergic activity with delirium in elderly medical patients. Am J Geriatr Psychiatry. 1998;6:31\u201341.","journal-title":"Am J Geriatr Psychiatry."},{"key":"321_CR51","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1176\/ajp.144.9.1218","volume":"144","author":"RC Golinger","year":"1987","unstructured":"Golinger RC, Peet T, Tune LE. Association of elevated plasma anticholinergic activity with delirium in surgical patients. Am J Psychiatry. 1987;144:1218\u201320.","journal-title":"Am J Psychiatry."},{"key":"321_CR52","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/jgs.12612","volume":"62","author":"L Watne","year":"2014","unstructured":"Watne L, Hall RJ, Molden E, et al. Anticholinergic activity in cerebrospinal fluid and serum in individuals with hip fracture with and without delirium. J Am Geriatr Soc. 2014;62:94\u2013102.","journal-title":"J Am Geriatr Soc."},{"key":"321_CR53","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/01.wnl.0000183152.16690.26","volume":"65","author":"RD Nebes","year":"2005","unstructured":"Nebes RD, Pollock BG, Meltzer CC, et al. Serum anticholinergic activity, white matter hyperintensities, and cognitive performance. Neurology. 2005;65:1487\u20139.","journal-title":"Neurology."},{"key":"321_CR54","doi-asserted-by":"crossref","first-page":"M12","DOI":"10.1093\/gerona\/54.1.M12","volume":"54","author":"JM Flacker","year":"1999","unstructured":"Flacker JM, Lipsitz LA. Serum anticholinergic activity changes with acute illness in elderly medical patients. J Gerontol A Biol Sci Med Sci. 1999;54:M12\u20136.","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"321_CR55","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/FTD.0b013e31829da990","volume":"36","author":"H Kersten","year":"2014","unstructured":"Kersten H, Wyller TB, Molden E. Association between inherited CYP2D6\/2C19 phenotypes and anticholinergic measures in elderly patients using anticholinergic drugs. Ther Drug Monit. 2014;36:125\u201330.","journal-title":"Ther Drug Monit."},{"key":"321_CR56","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2202-9-86","volume":"9","author":"C Thomas","year":"2008","unstructured":"Thomas C, Hestermann U, Kopitz J, et al. Serum anticholinergic activity and cerebral cholinergic dysfunction: an EEG study in frail elderly with and without delirium. BMC Neurosci. 2008;9:86.","journal-title":"BMC Neurosci."},{"key":"321_CR57","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1365-2044.2007.05255.x","volume":"62","author":"K Plaschke","year":"2007","unstructured":"Plaschke K, Hill H, Engelhardt R, et al. EEG changes and serum anticholinergic activity measured in patients with delirium in the intensive care unit. Anaesthesia. 2007;62:1217\u201323.","journal-title":"Anaesthesia."},{"key":"321_CR58","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1213\/ANE.0000000000000390","volume":"119","author":"A Rossi","year":"2014","unstructured":"Rossi A, Burkhart C, Dell-Kuster S, et al. Serum anticholinergic activity and postoperative cognitive dysfunction in elderly patients. Anesth Analg. 2014;119:947\u201355.","journal-title":"Anesth Analg."},{"key":"321_CR59","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1176\/jnp.2010.22.4.433","volume":"22","author":"K Plaschke","year":"2010","unstructured":"Plaschke K, Kopitz J, Mattern J, et al. Increased cortisol levels and anticholinergic activity in cognitively unimpaired patients. J Neuropsychiatry Clin Neurosci. 2010;22:433\u201341.","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"321_CR60","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jpsychires.2012.06.015","volume":"46","author":"BC Munster van","year":"2012","unstructured":"van Munster BC, Thomas C, Kreisel SH, et al. Longitudinal assessment of serum anticholinergic activity in delirium of the elderly. J Psychiatr Res. 2012;46:1339\u201345.","journal-title":"J Psychiatr Res."},{"key":"321_CR61","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1176\/ajp.155.8.1110","volume":"155","author":"BG Pollock","year":"1998","unstructured":"Pollock BG, Mulsant BH, Nebes R, et al. Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline. Am J Psychiatry. 1998;155:1110\u20132.","journal-title":"Am J Psychiatry."},{"key":"321_CR62","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00004714-200006000-00004","volume":"20","author":"KN Chengappa","year":"2000","unstructured":"Chengappa KN, Pollock BG, Parepally H, et al. Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine. J Clin Psychopharmacol. 2000;20:311\u20136.","journal-title":"J Clin Psychopharmacol."},{"key":"321_CR63","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.4088\/JCP.v65n1217","volume":"65","author":"BH Mulsant","year":"2004","unstructured":"Mulsant BH, Gharabawi GM, Bossie CA, et al. Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine. J Clin Psychiatry. 2004;65:1708\u201314.","journal-title":"J Clin Psychiatry."},{"key":"321_CR64","doi-asserted-by":"crossref","first-page":"M353","DOI":"10.1093\/gerona\/56.6.M353","volume":"56","author":"JM Flacker","year":"2001","unstructured":"Flacker JM, Wei JY. Endogenous anticholinergic substances may exist during acute illness in elderly medical patients. J Gerontol A Biol Sci Med Sci. 2001;56:M353\u20135.","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"321_CR65","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neulet.2007.02.015","volume":"417","author":"K Plaschke","year":"2007","unstructured":"Plaschke K, Thomas C, Engelhardt R, et al. Significant correlation between plasma and CSF anticholinergic activity in presurgical patients. Neurosci Lett. 2007;417:16\u201320.","journal-title":"Neurosci Lett."},{"key":"321_CR66","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0024-3205(93)90300-R","volume":"52","author":"AI Levey","year":"1993","unstructured":"Levey AI. Immunological localization of m1\u2013m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci. 1993;52:441\u20138.","journal-title":"Life Sci."},{"key":"321_CR67","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF02244079","volume":"103","author":"HV Curran","year":"1991","unstructured":"Curran HV, Schifano F, Lader M. Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood. Psychopharmacology (Berl). 1991;103:83\u201390.","journal-title":"Psychopharmacology (Berl)."},{"key":"321_CR68","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1532-5415.2011.03491.x","volume":"59","author":"C Fox","year":"2011","unstructured":"Fox C, Richardson K, Maidment ID, et al. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc. 2011;59:1477\u201383.","journal-title":"J Am Geriatr Soc."},{"key":"321_CR69","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s40266-013-0055-2","volume":"30","author":"J Uusvaara","year":"2013","unstructured":"Uusvaara J, Pitk\u00e4l\u00e4 KH, Kautiainen H, et al. Detailed cognitive function and use of drugs with anticholinergic properties in older people: a community-based cross-sectional study. Drugs Aging. 2013;30:177\u201382.","journal-title":"Drugs Aging."},{"key":"321_CR70","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jtcvs.2012.07.043","volume":"145","author":"K Plaschke","year":"2013","unstructured":"Plaschke K, Hauth S, Jansen C, et al. The influence of preoperative serum anticholinergic activity and other risk factors for the development of postoperative cognitive dysfunction after cardiac surgery. J Thorac Cardiovasc Surg. 2013;145:805\u201311.","journal-title":"J Thorac Cardiovasc Surg."},{"key":"321_CR71","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/11585060-000000000-00000","volume":"28","author":"J Uusvaara","year":"2011","unstructured":"Uusvaara J, Pitk\u00e4l\u00e4 KH, Kautiainen H, et al. Association of anticholinergic drugs with hospitalization and mortality among older cardiovascular patients: a prospective study. Drugs Aging. 2011;28:131\u20138.","journal-title":"Drugs Aging."},{"key":"321_CR72","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000322883","volume":"1","author":"MJ Luukkanen","year":"2011","unstructured":"Luukkanen MJ, Uusvaara J, Laurila JV, et al. Anticholinergic drugs and their effects on delirium and mortality in the elderly. Dement Geriatr Cogn Dis Extra. 2011;1:43\u201350.","journal-title":"Dement Geriatr Cogn Dis Extra."},{"key":"321_CR73","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/0091270010368410","volume":"51","author":"EK Kumpula","year":"2011","unstructured":"Kumpula EK, Bell JS, Soini H, et al. Anticholinergic drug use and mortality among residents of long-term care facilities: a prospective cohort study. J Clin Pharmacol. 2011;51:256\u201363.","journal-title":"J Clin Pharmacol."},{"issue":"Suppl 2","key":"321_CR74","doi-asserted-by":"crossref","first-page":"S277","DOI":"10.1111\/j.1532-5415.2011.03676.x","volume":"59","author":"N Campbell","year":"2011","unstructured":"Campbell N, Perkins A, Hui S, et al. Association between prescribing of anticholinergic medications and incident delirium: a cohort study. J Am Geriatr Soc. 2011;59(Suppl 2):S277\u201381.","journal-title":"J Am Geriatr Soc."},{"key":"321_CR75","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2165\/11317660-000000000-00000","volume":"26","author":"J Panula","year":"2009","unstructured":"Panula J, Puustinen J, Jaatinen P, et al. Effects of potent anticholinergics, sedatives and antipsychotics on postoperative mortality in elderly patients with hip fracture: a retrospective, population-based study. Drugs Aging. 2009;26:963\u201371.","journal-title":"Drugs Aging."},{"key":"321_CR76","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00433493","volume":"75","author":"L Tune","year":"1981","unstructured":"Tune L, Coyle JT. Acute extrapyramidal side effects: serum levels of neuroleptics and anticholinergics. Psychopharmacology (Berl). 1981;75:9\u201315.","journal-title":"Psychopharmacology (Berl)."},{"key":"321_CR77","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0140-6736(81)90847-3","volume":"2","author":"JC Harris","year":"1981","unstructured":"Harris JC, Tune LE, Allen M, et al. Management of akathisia in a severely retarded adolescent male with help of an anticholinergic drug assay. Lancet. 1981;2:414.","journal-title":"Lancet."}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-015-0321-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-015-0321-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-015-0321-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T21:01:42Z","timestamp":1653426102000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-015-0321-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,30]]},"references-count":77,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["321"],"URL":"https:\/\/doi.org\/10.1007\/s40266-015-0321-6","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,30]]}}}